Literature DB >> 11530051

Pigment epithelium-derived factor in the vitreous is low in diabetic retinopathy and high in rhegmatogenous retinal detachment.

N Ogata1, J Tombran-Tink, M Nishikawa, T Nishimura, Y Mitsuma, T Sakamoto, M Matsumura.   

Abstract

PURPOSE: To report the levels of pigment epithelium-derived factor in the vitreous of patients with diabetic retinopathy, rhegmatogenous retinal detachment, and idiopathic macular hole.
METHODS: Using enzyme-linked immunosorbent assay, we measured the levels of pigment epithelium-derived factor in the vitreous of 34 eyes of 33 patients who underwent vitrectomy for the treatment of diabetic retinopathy (17 eyes of 16 patients), rhegmatogenous retinal detachment (10 eyes), and idiopathic macular hole (seven eyes).
RESULTS: The vitreal concentration of pigment epithelium-derived factor was 1.15 +/- 0.23 microg/ml (mean +/- standard error) in eyes with diabetic retinopathy, 3.28 +/- 0.69 microg/ml in rhegmatogenous retinal detachment, and 1.71 +/- 0.39 microg/ml in idiopathic macular hole. The pigment epithelium-derived factor level in rhegmatogenous retinal detachment was significantly higher than that in diabetic retinopathy (P =.0008) and idiopathic macular hole (P =.034). For eyes with diabetic retinopathy, the pigment epithelium-derived factor level was 0.88 +/- 0.21 microg/ml in proliferative diabetic retinopathy and 2.43 +/- 0.37 microg/ml in nonproliferative diabetic retinopathy (P =.0083). Additionally, the pigment epithelium-derived factor level in active diabetic retinopathy (0.70 +/- 0.22 microg/ml) was significantly lower than the level in inactive diabetic retinopathy (1.79 +/- 0.35 microg/ml; P =.018).
CONCLUSIONS: These results suggest that pigment epithelium-derived factor inhibits angiogenesis and that lower levels of pigment epithelium-derived factor may be related to the angiogenesis in diabetic retinopathy and result in active proliferative diabetic retinopathy. The results also suggest that higher levels of pigment epithelium-derived factor in the eyes with rhegmatogenous retinal detachment may act as a neuroprotective agent for the detached retina.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11530051     DOI: 10.1016/s0002-9394(01)01008-x

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  27 in total

1.  Influence of vitreous factors after vitrectomy for macular edema in patients with central retinal vein occlusion.

Authors:  Hidetaka Noma; Hideharu Funatsu; Tatsuya Mimura; Shuichiro Eguchi; Katsunori Shimada
Journal:  Int Ophthalmol       Date:  2011-11-22       Impact factor: 2.031

Review 2.  Biomarkers of Diabetic Retinopathy.

Authors:  Daniel Shu Wei Ting; Kara-Anne Tan; Val Phua; Gavin Siew Wei Tan; Chee Wai Wong; Tien Yin Wong
Journal:  Curr Diab Rep       Date:  2016-12       Impact factor: 4.810

Review 3.  Gene Therapies for Neovascular Age-Related Macular Degeneration.

Authors:  Peter Pechan; Samuel Wadsworth; Abraham Scaria
Journal:  Cold Spring Harb Perspect Med       Date:  2014-12-18       Impact factor: 6.915

4.  Proteomic analysis of human vitreous fluid by fluorescence-based difference gel electrophoresis (DIGE): a new strategy for identifying potential candidates in the pathogenesis of proliferative diabetic retinopathy.

Authors:  M García-Ramírez; F Canals; C Hernández; N Colomé; C Ferrer; E Carrasco; J García-Arumí; R Simó
Journal:  Diabetologia       Date:  2007-03-23       Impact factor: 10.122

5.  Positive correlation of pigment epithelium-derived factor and total antioxidant capacity in aqueous humour of patients with uveitis and proliferative diabetic retinopathy.

Authors:  Yumiko Yoshida; Sho-ichi Yamagishi; Takanori Matsui; Kazuo Nakamura; Tsutomu Imaizumi; Koichi Yoshimura; Ryoji Yamakawa
Journal:  Br J Ophthalmol       Date:  2007-03-27       Impact factor: 4.638

6.  Expression of pigment epithelium derived factor and vascular endothelial growth factor in choroidal neovascular membranes and polypoidal choroidal vasculopathy.

Authors:  M Matsuoka; N Ogata; T Otsuji; T Nishimura; K Takahashi; M Matsumura
Journal:  Br J Ophthalmol       Date:  2004-06       Impact factor: 4.638

7.  Identification of the antivasopermeability effect of pigment epithelium-derived factor and its active site.

Authors:  Hua Liu; Jian-Guo Ren; William L Cooper; Charles E Hawkins; Mitra R Cowan; Patrick Y Tong
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-19       Impact factor: 11.205

8.  Levels of vascular endothelial growth factor and pigment epithelium-derived factor in eyes before and after intravitreal injection of bevacizumab.

Authors:  Kayako Matsuyama; Nahoko Ogata; Nobuo Jo; Chieko Shima; Masato Matsuoka; Miyo Matsumura
Journal:  Jpn J Ophthalmol       Date:  2009-05-31       Impact factor: 2.447

9.  Leukostasis and pigment epithelium-derived factor in rat models of diabetic retinopathy.

Authors:  Masato Matsuoka; Nahoko Ogata; Keizo Minamino; Miyo Matsumura
Journal:  Mol Vis       Date:  2007-06-29       Impact factor: 2.367

10.  Ratio of the vitreous vascular endothelial growth factor and pigment epithelial-derived factor in Eales disease.

Authors:  Narayanasamy Angayarkanni; Radhakrishnan Selvi; Rishi Pukhraj; Jyotirmoy Biswas; Shah J Bhavesh; Joyce Tombran-Tink
Journal:  J Ocul Biol Dis Infor       Date:  2009-03-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.